BCL2 and lymphoma: In addition, ABT‐199 (venetoclax) was tested, which is also a BH3‐mimetic drug that highly selectively inhibits Bcl‐2 and therefore effectively induces apoptosis in Bcl‐2 dependent lymphoma.16, 17